{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:11:41Z","timestamp":1792638701641,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA229836"],"award-info":[{"award-number":["R01CA229836"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022713","name":"Charlie Teo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.canlet.2022.215898","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T22:24:20Z","timestamp":1662416660000},"page":"215898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity"],"prefix":"10.1016","volume":"548","author":[{"given":"Mingjing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Lee","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Sze","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K-C","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215898_bib1","first-page":"11","article-title":"Cancer cells tune the signaling pathways to empower de Novo synthesis of nucleotides","author":"Villa","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215898_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1389203013380991","article-title":"The role of dUTPase and uracil-DNA repair in cancer chemotherapy","volume":"2","author":"Ladner","year":"2001","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.canlet.2022.215898_bib3","first-page":"3493","article-title":"dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer","volume":"60","author":"Ladner","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215898_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/1535-7163.MCT-11-0781","article-title":"Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer","volume":"11","author":"Wilson","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2022.215898_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.2008.060004","article-title":"Higher expression of deoxyuridine triphosphatase (dUTPase) may predict the metastasis potential of colorectal cancer","volume":"62","author":"Kawahara","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2022.215898_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1478-3231.2009.02177.x","article-title":"dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma","volume":"30","author":"Takatori","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2022.215898_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2022.215898_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215898_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215898_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215898_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2022.215898_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13046-019-1412-8","article-title":"Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2022.215898_bib13","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1073\/pnas.1903244116","article-title":"TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy","volume":"116","author":"McLoughlin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215898_bib14","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","article-title":"Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo","volume":"11","author":"Coriat","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2022.215898_bib15","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215898_bib16","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1508779113","article-title":"Transketolase counteracts oxidative stress to drive cancer development","volume":"113","author":"Xu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215898_bib17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI90253","article-title":"Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma","volume":"127","author":"Lee","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2022.215898_bib18","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/1078-0432.CCR-15-1987","article-title":"NDUFA4L2 fine-tunes oxidative stress in hepatocellular carcinoma","volume":"22","author":"Lai","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2022.215898_bib19","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1158\/0008-5472.CAN-07-6469","article-title":"Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest","volume":"68","author":"Gho","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215898_bib20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-term expansion of functional mouse and human hepatocytes as 3D organoids","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215898_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature13181","article-title":"MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool","volume":"508","author":"Gad","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215898_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215898_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","article-title":"SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond","volume":"39","author":"Schaefer","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215898_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13578-020-00521-0","article-title":"BIRC3 and BIRC5: multi-faceted inhibitors in cancer","volume":"11","author":"Frazzi","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2022.215898_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrc2465","article-title":"The TRAIL apoptotic pathway in cancer onset, progression and therapy","volume":"8","author":"Johnstone","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215898_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.27859","article-title":"Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice","volume":"62","author":"Lo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215898_bib27","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2022.215898_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2022.215898_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110236","article-title":"Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells","volume":"38","author":"Abt","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215898_bib30","doi-asserted-by":"crossref","first-page":"59299","DOI":"10.18632\/oncotarget.11151","article-title":"Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage","volume":"7","author":"Yan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215898_bib31","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/cddis.2011.135","article-title":"Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair","volume":"3","author":"Bulgar","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215898_bib32","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/1535-7163.MCT-13-0172","article-title":"Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed","volume":"12","author":"Weeks","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2022.215898_bib33","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1158\/0008-5472.CAN-17-1965","article-title":"Skp2-Mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215898_bib34","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1093\/nar\/gkaa175","article-title":"The genomic landscape of 8-oxodG reveals enrichment at specific inherently fragile promoters","volume":"48","author":"Gorini","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2022.215898_bib35","doi-asserted-by":"crossref","first-page":"36241","DOI":"10.1074\/jbc.M607965200","article-title":"Incorporation and replication of 8-oxo-deoxyguanosine by the human mitochondrial DNA polymerase","volume":"281","author":"Hanes","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215898_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14045","article-title":"Oxidized nucleotide insertion by pol beta confounds ligation during base excision repair","volume":"8","author":"Caglayan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215898_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2022.215898_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2022.215898_bib39","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/nar\/18.19.5775","article-title":"The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence (TGACGTCA) is reduced by the misincorporation of U and increased by the deamination of C","volume":"18","author":"Verri","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2022.215898_bib40","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1074\/jbc.M208102200","article-title":"Effects of endogenous DNA base lesions on transcription elongation by mammalian RNA polymerase II. Implications for transcription-coupled DNA repair and transcriptional mutagenesis","volume":"278","author":"Kuraoka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215898_bib41","doi-asserted-by":"crossref","first-page":"18511","DOI":"10.1074\/jbc.M313598200","article-title":"Single-stranded breaks in DNA but not oxidative DNA base damages block transcriptional elongation by RNA polymerase II in HeLa cell nuclear extracts","volume":"279","author":"Kathe","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215898_bib42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nature08033","article-title":"dUTP incorporation into genomic DNA is linked to transcription in yeast","volume":"459","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215898_bib43","doi-asserted-by":"crossref","first-page":"22008","DOI":"10.1074\/jbc.M113.521807","article-title":"Excision of uracil from transcribed DNA negatively affects gene expression","volume":"289","author":"Luhnsdorf","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215898_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-020-0397-4","article-title":"New uracil analog U-332 is an inhibitor of NF-kappaB in 5-fluorouracil-resistant human leukemia HL-60 cell line","volume":"21","author":"Dlugosz-Pokorska","year":"2020","journal-title":"BMC Pharmacol. Toxicol."}],"updated-by":[{"DOI":"10.1016\/j.canlet.2023.216601","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:05:29Z","timestamp":1759593929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522003822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"alternative-id":["S0304383522003822"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215898","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215898"}}